SCHEMBL8558767

SCHEMBL8558767

Cc1c(F)c(N2CCNCC2)cc2c1c(=O)c(C(=O)O)cn2-c1ccc(F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.67
ALDH1A1 P00352 5/20 0.67
KDM4E B2RXH2 5/20 0.67
HPGD P15428 3/20 0.67
HSD17B10 Q99714 3/20 0.67
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
KCNH2 Q12809 1/20 0.53
HRH3 Q9Y5N1 1/20 0.53
HTT P42858 2/20 0.47
BRD4 O60885 1/20 0.47
TSHR P16473 1/20 0.47
CYP2J2 P51589 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TOP2A P11388 4/20 0.45
TOP2B Q02880 3/20 0.45
CYP2C9 P11712 2/20 0.45
CYP1A2 P05177 1/20 0.45
TOP1 P11387 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8556212 0.89 LMNA (0.69) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8621440 0.89 LMNA (0.57) LMNAALDH1A1KDM4EHPGDHSD17B10
Hydrochloric Acid SCHEMBL8554393 0.88 LMNA (0.58) LMNAALDH1A1KDM4EHPGDHSD17B10
Hydrochloric Acid SCHEMBL8110971 0.82 KCNH2 (0.51) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8188064 0.82 LMNA (0.66) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8112233 0.81 LMNA (0.51) LMNAALDH1A1KDM4EHPGDHSD17B10
Sarafloxacin SCHEMBL311593 0.81 ALDH1A1 (0.98) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8554870 0.81 HSD17B10 (0.68) LMNAALDH1A1KDM4EHPGDHSD17B10
Sarafloxacin SCHEMBL379212 0.80 ALDH1A1 (1.00) LMNAALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8554680 0.80 KCNH2 (0.79) LMNAALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811576-A 1-CARBOXY-2-LOWERALKYL-3,4,6-TRI(HALO)BENZENES; GRAMPOSITIVE AND-NEGATIVE BACTERIA; INFECTIONS; STERILIZATION OF MEDICAL EQUIPMENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-09-22 US disclosed
US-5723648-A Intermediates for anti-microbial benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-03-03 US disclosed
EP-0823413-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed
US-5563138-A 4-OXOQUINOLINE-3-CARBOXYLIC ACID COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1996-10-08 US disclosed
EP-0287951-B1 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMA CO LTD (JP) 1996-07-03 EP disclosed
US-5290934-A Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-03-01 US disclosed
EP-0565132-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-10-13 EP disclosed
EP-0287951-A2 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-10-26 EP disclosed